Skip to content

Reported October 29, 2024 · Before market open

Revenue$10.0M
EPS$1.02

Next report

Oct 22, 2026 (in 3 months)

Financials

Q3 2024

Income statement

See full
Revenue$10.0M-20.0%
Gross profit$5.8M-21.2%
Operating income$3.3M-15.8%
Net income$3.6M-9.5%
EPS (diluted)$1.03-4.6%

Balance sheet

See full
Cash & equivalents$88.5M+0.3%
Total debt$299.0K-2.0%
Total equity$124.2M+0.4%
Total assets$129.7M-1.2%

Cash flow

See full
Operating cash flow$3.9M-24.7%
CapEx$89.0K-52.2%
Free cash flow$3.8M-23.7%

Valuation & ratios

Valuation

as of 09/30/24
See full
Market cap$242.17M-22.4%
Enterprise value$154.02M-31.3%
P/E15.9×-2.6×
P/S5.5×-0.6×

Profitability

See full
Gross margin58.8%-2.0pp
Operating margin33.1%-1.6pp
Net margin34.6%+1.8pp
FCF margin38.4%-4.5pp

Returns & leverage

See full
Return on equity12.3%-2.3pp
Debt / equity0.0×
Current ratio29.6×+5.2×

Segments

By geography

See full
Global$10.2M-18.6%
Domestic Us$5.7M-21.7%
Ous$4.4M-20.7%
Outside Us$4.3M-17.6%

By product

See full
Gynecology Electrosurgery Urology$5.1M-5.2%
Blood Pressure Monitoring And Accessories$2.1M-43.9%
Neonatal$1.7M-9.1%
Obstetrics$1.1M-26.0%

Versus estimates

Ask the moment Utah Medical Products reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Utah Medical Products report Q3 2024 earnings?
Utah Medical Products (UTMD) reported Q3 2024 earnings on October 29, 2024 before market open.
What were Utah Medical Products's Q3 2024 revenue and EPS?
Utah Medical Products reported revenue of $10.0M and eps of $1.02 for Q3 2024.
Where can I find Utah Medical Products's Q3 2024 SEC filings?
You can read the 10-Q periodic report (0001811884-24-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.